New to Meducation?
Sign up
Already signed up? Log In
view moderators

MultipleSclerosis

Category

Preview
0
31

'First Clinical Evidence' of Remyelination in MS

Researchers report what they call 'the first clinical study to show evidence of proof of biology for remyelination in multiple sclerosis': improved optic nerve conduction in optic neuritis.  
medscape.com
over 5 years ago
Preview
0
0

'First Clinical Evidence' of Remyelination in MS

Researchers report what they call 'the first clinical study to show evidence of proof of biology for remyelination in multiple sclerosis': improved optic nerve conduction in optic neuritis.  
medscape.com
over 5 years ago
Preview
0
7

FDA Approves First Generic Copaxone in Multiple Sclerosis

A generic version of the standard MS therapy glatiramer acetate receives FDA approval.  
medscape.com
over 5 years ago
Preview
0
4

MS drug 'may already be out there' | Nursing in Practice

Depression and heart-disease drugs are to be tested in a trial to find treatments for multiple sclerosis (MS) from existing medicines. There are currently no treatments in the secondary progressive stage of the debilitating disease. Doctors hope the necessary drugs are already out there, but have never been tested on MS.  
nursinginpractice.com
over 5 years ago
Preview
0
9

MS drug 'may already be out there' - BBC News

Depression and heart-disease drugs are to be tested in a trial to find treatments for Multiple Sclerosis (MS) from existing medicines.  
bbc.co.uk
over 5 years ago
Preview
0
8

MS drug 'may already be out there' - BBC News

Depression and heart disease drugs are to be tested in a new trial to find treatments for Multiple Sclerosis (MS).  
bbc.co.uk
over 5 years ago
Preview
0
13

HIV and multiple sclerosis: beginning to unravel a mystery

Stream HIV and multiple sclerosis: beginning to unravel a mystery by BMJ talk medicine from desktop or your mobile device  
feeds.bmj.com
over 5 years ago
Preview
0
19

Diagnosing and treating neuromyelitis optica

Stream Diagnosing and treating neuromyelitis optica by BMJ talk medicine from desktop or your mobile device  
feeds.bmj.com
over 5 years ago
Preview
0
10

Dimethyl fumarate (BG-12) first line oral treatment for people with multiple sclerosis | Cochrane

Dimethyl fumarate was approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency for adults with relapsing-remitting multiple sclerosis (RRMS). It does not require that any other medication be tried before dimethyl fumarate is prescribed. Although data from non Cochrane reviews are available, it is important to systematically evaluate its efficacy and safety as monotherapy versus placebo.  
cochrane.org
over 5 years ago
Preview
0
12

Telerehabilitation for persons with multiple sclerosis | Cochrane

Does telerehabilitation achieve better outcomes in persons with multiple sclerosis compared with traditional face-to-face intervention? What types of telerehabilitation interventions are effective, in which setting and influence which specific outcomes?  
cochrane.org
over 5 years ago
Preview
0
1

The management of spasticity in adults

Spasticity is a frequent and debilitating feature of common neurological conditions such as stroke, multiple sclerosis, and traumatic brain and spinal cord injuries  
feeds.bmj.com
about 5 years ago
Preview
0
8

The struggle of being a parent with multiple sclerosis - BBC News

Nicola Smith, who has multiple sclerosis, tells the Victoria Derbyshire programme she is worried that her condition will lead her son to miss out.  
bbc.co.uk
about 5 years ago
Preview
0
6

Low vitamin-D genes linked to MS - BBC News

People genetically prone to low vitamin-D levels are at increased risk of multiple sclerosis, a large study suggests.  
bbc.co.uk
about 5 years ago
Preview
0
0

Exercise therapy for fatigue in multiple sclerosis | Cochrane

Multiple sclerosis (MS) is a chronic disease affecting over 1.3 million people globally. MS is characterized by diffuse damage to the central nervous system, leading to a wide range of different physical and cognitive (mental processes) symptoms. One of the most prominent and disabling symptoms of MS is fatigue. Currently, there is no effective medicine to reduce fatigue in people with MS. Treatment with exercise may be a way to reduce fatigue either directly by changing how the body works, for example hormonal function, or indirectly through improved physical activity and general health.  
cochrane.org
about 5 years ago
Preview
0
0

Smoking May Speed Up MS Disease Course

Continued smoking after a diagnosis of multiple sclerosis may be associated with accelerated disease progression, a new study suggests.  
medscape.com
about 5 years ago
Preview
0
0

Prognostic Factors for Developing Multiple Sclerosis

What are the characteristics that might predict multiple sclerosis development and disability accumulation?  
medscape.com
about 5 years ago
Preview
0
0

Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis | Cochrane

Different therapeutic strategies are available for the treatment of people with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants, and biologics. Although there is consensus that these therapies may reduce the frequency of relapses, their relative benefit (effectiveness compared to each other) in delaying new relapses or disability worsening remains unclear due to the limited number of direct comparison studies (i.e. studies comparing two or more active agents with each other).  
cochrane.org
about 5 years ago
Preview
0
0

Effective Patient Communication for Multiple Sclerosis Treatment Success CME/CE

This activity is intended for clinicians including neurologists, primary care physicians, obstetricians and gynecologists who care for patients with MS.  
medscape.org
about 5 years ago
Preview
0
0

Cannabinoids and the Progression of Multiple Sclerosis

This study aimed to determine if THC might slow the progressive phase of MS by way of its neuroprotective properties.  
medscape.com
about 5 years ago